Nitroimidazole derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme.

Nitroimidazole derivatives dose-dependently decreased basal and CRF-stimulated ACTH release, basal and GRF-stimulated rat GH release, and basal rat PRL release in primary cultures of rat anterior pituitary cells. In addition, basal and CRF-stimulated mRNA coding for the ACTH precursor were reduced after preincubation with the nitroimidazole derivatives. Miconazole, econazole, isoconazole, clotrimazole, and bifonazole had similar or more pronounced effects on anterior pituitary function compared to ketoconazole, whereas metronidazole and etomidate were less effective. The positive correlation between the number of phenylated side-chains or phenolic rings of the imidazole molecule and the efficacy to inhibit activity on pituitary hormone secretion suggests a structure-activity relationship of these compounds. The effects of the nitroimidazole derivatives on anterior pituitary hormone release and biosynthesis were mediated by cAMP. Thus, basal and CRF-, cholera toxin-, and forskolin-stimulated adenylate cyclase activities in rat anterior pituitary cell membranes determined by cAMP formation were suppressed by the nitroimidazole derivatives. Pertussis toxin did not diminish the nitroimidazole derivative effect on cAMP formation. The adenylate cyclase inhibitory effect of these substances was independent of the presence of GTP in the assay system, underlining a direct effect on the catalytic subunit. In addition, basal and forskolin-stimulated cAMP generation in membranes of S49 lymphoma cyc-variants, which lack a functional Gs protein, was efficiently suppressed (by up to 90%) by the nitroimidazole derivatives. In conclusion, ketoconazole and other nitroimidazole derivatives inhibit anterior pituitary hormone synthesis and secretion apparently by a direct effect on the catalytic subunit of the adenylate cyclase system.

[1]  L. Kennedy,et al.  CLINICAL EXPERIENCE WITH KETOCONAZOLE AS A THERAPY FOR PATIENTS WITH CUSHING'S SYNDROME , 1987, Clinical endocrinology.

[2]  A. Herz,et al.  GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells. , 1987, Molecular pharmacology.

[3]  M. Tagliaferri,et al.  Use of ketoconazole in the treatment of Cushing's syndrome. , 1986, The Journal of clinical endocrinology and metabolism.

[4]  D. Feldman,et al.  Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. , 1986, Endocrine reviews.

[5]  F. De Clerck,et al.  Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. , 1986, Biochemical pharmacology.

[6]  S. Bloom,et al.  Effect of ketoconazole on adrenocorticotrophic hormone secretion in vitro and in vivo. , 1986, The Journal of endocrinology.

[7]  J. Schopohl,et al.  Corticotropin-releasing factor in humans. I. CRF stimulation in normals and CRF radioimmunoassay. , 1986, Hormone research.

[8]  N. Kley,et al.  Corticotropin-releasing factor and forskolin increase proopiomelanocortin messenger RNA levels in rat anterior and intermediate cells in vitro , 1985, Neuroscience Letters.

[9]  M. Boscaro,et al.  Prolonged treatment of Cushing's disease by ketoconazole. , 1985, The Journal of clinical endocrinology and metabolism.

[10]  R. Gärtner,et al.  Involvement of cyclic AMP, iodide and metabolites of arachidonic acid in the regulation of cell proliferation of isolated porcine thyroid follicles , 1985, Molecular and Cellular Endocrinology.

[11]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[12]  E. Hewlett,et al.  Human pancreatic tumor growth hormone (GH) - releasing factor and cyclic adenosine 3',5'- monophosphate evoke GH release from anterior pituitary cells: the effects of pertussis toxin, cholera toxin, forskolin, and cycloheximide. , 1984, Endocrinology.

[13]  E. Nieschlag,et al.  Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis. , 1984, Acta endocrinologica.

[14]  D. Feldman,et al.  Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. , 1983, The Journal of clinical investigation.

[15]  G. Schultz,et al.  Occurrence of an inhibitory guanine nucleotide-binding regulatory component of the adenylate cyclase system in cyc- variants of S49 lymphoma cells. , 1983, European journal of biochemistry.

[16]  D. Stevens,et al.  Ketoconazole blocks testosterone synthesis. , 1982, Archives of internal medicine.

[17]  D. Stevens,et al.  Ketoconazole blocks adrenal steroid synthesis. , 1982, Annals of internal medicine.

[18]  B. White,et al.  Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. , 1982, The Journal of biological chemistry.

[19]  R. Maurer.  Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP , 1981, Nature.

[20]  H. van den Bossche,et al.  In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis , 1980, Antimicrobial Agents and Chemotherapy.

[21]  P. Seeburg,et al.  Corticotropin and beta-endorphin: construction and analysis of recombinant DNA complementary to mRNA for the common precursor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Cooper,et al.  Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Schultz,et al.  Inhibition of platelet adenylate cyclase by epinephrine requires GTP , 1978, FEBS letters.